BMP Signaling Pathway: Molecular Components, Signal Transduction Mechanisms, and Biological Functions

The BMP pathway is one of the most representative developmental and homeostatic regulatory pathways within the TGF-β superfamily. It participates in embryonic patterning, bone and cartilage formation, vascular and neural development, stem cell fate determination, and tissue repair. A defining feature of BMP signaling is not that a single ligand activates a single endpoint, but that ligands, receptors, extracellular antagonists, the Smad transcriptional module, and non-Smad branches together determine signal strength, duration, and functional output in different cellular contexts.

Keywords: BMP; BMPR; Smad1; Smad5; Smad8; ALK; TGF-β superfamily; developmental signaling pathway

1 Basic Framework of the BMP Pathway

1.1 Molecular Classification of the BMP Family

(1) Position of BMPs within the TGF-β superfamily

BMP stands for bone morphogenetic protein. It was originally named for its ability to induce ectopic bone formation, but its functions extend far beyond osteogenesis. The BMP family belongs to the TGF-β superfamily together with TGF-β, Activin, Nodal, and related factors, and these ligands generally regulate transcription through serine/threonine kinase receptors and Smad proteins.

(2) Range of BMP ligands

Common BMP ligands include BMP2, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, BMP9, BMP10, as well as GDF5, GDF6, and GDF7. Different members show substantial differences in tissue distribution, receptor preference, and functional emphasis. BMP2/4 are more commonly associated with embryonic patterning and osteogenic differentiation; BMP6/7 are more often linked to kidney biology, iron metabolism, and regeneration; BMP9/10 show particularly prominent roles in vascular homeostasis and endothelial signaling.

(3) Precursor processing and mature ligand formation

BMP ligands are generally synthesized as precursor proteins and subsequently processed proteolytically to release the C-terminal mature domain. Mature BMPs function as dimers and may form homodimers or, under specific conditions, heterodimers. Different dimeric forms differ in receptor affinity and signaling activity.

1.2 Core Components of the BMP Pathway

(1) Ligand level

BMP ligands constitute the starting point of signaling. Their local concentration, diffusion range, precursor processing efficiency, and binding state with antagonistic molecules together determine effective signaling input.

(2) Receptor level

BMP signaling depends on two classes of transmembrane serine/threonine kinase receptors, namely type I and type II receptors. Type I receptors mainly include ALK1, ALK2, ALK3, and ALK6, whereas type II receptors mainly include BMPR2, ACVR2A, and ACVR2B. Different ligands show preferences for distinct receptor combinations, which contributes to tissue-specific signaling output.

(3) Intracellular transduction level

Canonical BMP signaling is mainly mediated by Smad1, Smad5, and Smad8/9, which subsequently form complexes with the common Smad, Smad4, and translocate into the nucleus to regulate target gene expression.

(4) Regulatory level

The BMP pathway is also regulated by extracellular antagonistic proteins, receptor endocytosis and degradation, inhibitory Smads, ubiquitin systems, dephosphorylation-mediated inactivation, and crosstalk with other signaling pathways. Its output is therefore the result of dynamic equilibrium rather than a linear one-way process.

2 Recognition Mechanisms Between BMP Ligands and Receptors

2.1 Ligand-Receptor Binding Patterns

(1) Cooperative recognition by type I and type II receptors

Mature BMP dimers generally bind both type I and type II receptors. The kinase domains of type II receptors are usually constitutively active. After ligand-induced receptor complex formation, type II receptors phosphorylate and activate type I receptors. Activated type I receptors then phosphorylate downstream R-Smads, namely Smad1/5/8.

(2) Receptor combinations determine signaling properties

The same BMP ligand can engage different receptor combinations in different cell types. For example, BMP2 and BMP4 often favor ALK3/ALK6, BMP6 and BMP7 can efficiently utilize ALK2, whereas BMP9 and BMP10 are more prominently associated with ALK1. The receptor expression profile therefore becomes a major variable determining signaling direction.

(3) Coupling effect between ligand concentration and receptor abundance

BMP signaling intensity is not determined solely by ligand abundance. If receptor expression is insufficient, extracellular antagonists are excessive, or the ratio of type I to type II receptors is imbalanced, only weak activation may occur even in the presence of ligand. Conversely, under conditions of high receptor expression, relatively low ligand concentrations may still trigger marked transcriptional responses.

Table 1. Receptor Preferences and Major Functional Directions of Common BMP Ligands

Ligand	Common Type I Receptor Preference	Common Type II Receptors	Major Functional Direction
BMP2	ALK3, ALK6	BMPR2, ACVR2A/B	Osteogenic differentiation, embryonic patterning
BMP4	ALK3, ALK6	BMPR2, ACVR2A/B	Mesoderm induction, organ development
BMP6	ALK2, ALK3	BMPR2, ACVR2A/B	Iron metabolism, osteogenesis, regeneration
BMP7	ALK2, ALK3, ALK6	BMPR2, ACVR2A/B	Kidney development, anti-fibrosis, osteogenesis
BMP9	ALK1, ALK2	BMPR2, ACVR2A/B	Vascular homeostasis, endothelial signaling
BMP10	ALK1	BMPR2, ACVR2A/B	Cardiovascular development and endothelial regulation
GDF5	ALK6, ALK3	BMPR2, ACVR2A/B	Joint and cartilage development

2.2 Structural Features of Receptor Activation

(1) GS domain activation

The intracellular GS domain of type I receptors is the key structural element for receptor activation. Following ligand-induced complex formation, type II receptors phosphorylate the GS domain of type I receptors, relieving inhibitory constraints and enabling substrate recognition.

(2) Substrate selectivity

Once activated, type I receptors mainly recognize Smad1/5/8, whereas TGF-β/Activin-type receptors more commonly recognize Smad2/3. Accordingly, R-Smad selectivity after receptor activation is an important point of divergence between the BMP branch and other TGF-β superfamily branches.

3 Canonical Smad Signal Transduction in the BMP Pathway

3.1 Activation Process of Smad1/5/8

(1) C-terminal phosphorylation

Activated type I receptors phosphorylate the C-terminal SSXS motif of Smad1, Smad5, and Smad8/9. This event is the central initiating step of the canonical BMP pathway and one of the most commonly used direct experimental readouts.

(2) Smad complex formation

Phosphorylated Smad1/5/8 forms heteromeric complexes with Smad4 and translocates from the cytoplasm into the nucleus. If Smad4 is insufficient or its nuclear transport is impaired, upstream receptor activation may still occur, but transcriptional output from BMP signaling will be markedly restricted.

(3) Nuclear transcriptional regulation

Once in the nucleus, Smad complexes generally do not execute highly specific transcriptional regulation on their own. Instead, they cooperate with transcriptional regulators such as Runx2, Dlx5, Osterix, members of the Id family, and chromatin-remodeling complexes to determine target gene expression profiles.

3.2 Canonical BMP Target Genes

(1) Id family

Id1, Id2, and Id3 are commonly regarded as classical early-response genes of BMP signaling and are suitable for evaluating pathway activation status. Their upregulation generally indicates effective activation of the Smad1/5/8 transcriptional module.

(2) Runx2- and Sp7/Osterix-related programs

During osteogenic differentiation, BMP signaling can promote the upregulation of transcriptional programs centered on Runx2 and Sp7, thereby driving mesenchymal cells toward the osteoblastic lineage.

(3) Hepcidin-related regulation

In hepatocytes, the BMP6-HJV-SMAD axis promotes HAMP transcription and regulates iron homeostasis. This indicates that the BMP pathway is not limited to development and osteogenesis, but also participates deeply in systemic metabolic control.

3.3 Context Dependence of Nuclear Regulation

(1) Cell type dependence

The same BMP signal can trigger different gene expression programs in different cell types. This difference does not arise from intrinsic changes in Smad1/5/8 themselves, but from variation in co-transcription factors, chromatin accessibility, and cooperating pathways within each cell type.

(2) Signal strength dependence

Low-level and high-level BMP signaling do not produce identical transcriptional outcomes. In some developmental processes, the signal intensity gradient itself serves as an essential carrier of patterning information.

(3) Duration dependence

Transient and sustained activation also differ in transcriptional consequence. Short-term BMP stimulation may induce only early response genes, whereas prolonged stimulation may drive lineage reprogramming, cell-cycle changes, or terminal differentiation.

4 Noncanonical Branches of the BMP Pathway

4.1 MAPK-Related Branches

(1) p38 MAPK

In some cell types, BMP can activate the TAK1-p38 axis and participate in stress responses, differentiation control, and inflammation-related programs. This pathway often exists in parallel with the Smad branch.

(2) ERK pathway

The relationship between ERK and the BMP pathway is relatively complex. In some settings, ERK acts as a noncanonical output of BMP signaling; in others, ERK inhibits Smad1 activity through linker-region phosphorylation, thereby exerting bidirectional regulatory effects.

(3) JNK pathway

JNK activation can be observed in some developmental, stress, and inflammatory models, but whether it constitutes a core BMP output branch is often model-dependent.

4.2 PI3K-AKT and Metabolic Coupling

In certain stem cell and metabolism-related cell types, BMP signaling can interact with the PI3K-AKT pathway and influence cell survival, metabolic reprogramming, and differentiation windows. Although this branch is not the most canonical output of BMP signaling, it can exert important modifying effects on phenotype in specific contexts.

4.3 Small GTPases and Cytoskeletal Regulation

In models related to migration, polarity establishment, and morphogenesis, BMP signaling can also regulate cell morphology through Rho family small GTPases and downstream cytoskeletal modules. This layer is particularly important in neurite formation, epithelial remodeling, and vascular development.

5 Extracellular Regulatory Network of the BMP Pathway

5.1 Extracellular Antagonistic Molecules

(1) Noggin

Noggin binds BMP2, BMP4, and related ligands with high affinity and prevents them from interacting with receptors. It is one of the most classical extracellular antagonists of BMP signaling.

(2) Chordin

By binding BMP ligands and restricting their diffusion and receptor accessibility, Chordin plays a key role in dorsoventral patterning during embryogenesis.

(3) Gremlin and related antagonistic proteins

These molecules can fine-tune the spatial distribution of BMP signaling in different tissues, such that ligand presence does not necessarily mean receptor activation.

5.2 Coreceptors and Auxiliary Molecules

(1) HJV

Hemojuvelin plays an important role in BMP6-mediated regulation of iron homeostasis and can enhance the responsiveness of specific cells to BMP signaling.

(2) Endoglin

In endothelial-related BMP signaling, Endoglin can participate in stabilizing receptor complexes and modulating signaling bias, with particularly prominent significance in the BMP9/10-ALK1 axis.

5.3 Spatial Significance of Extracellular Regulation

One of the important features of BMP signaling in development is the combination of diffusible ligands with local antagonistic networks. What truly determines whether a given region receives effective BMP signaling is not merely the amount of ligand produced, but also the distribution of antagonistic proteins, diffusion dynamics, and receptor expression domains.

6 Intracellular Negative Feedback and Termination Mechanisms of the BMP Pathway

6.1 Inhibitory Smads

(1) Smad6

Smad6 is the most representative inhibitory Smad in the BMP pathway and shows strong preference for the BMP branch. It can interfere with Smad1/5/8-Smad4 complex formation and can also inhibit receptor-substrate interactions.

(2) Smad7

Although Smad7 is more commonly regarded as an inhibitor of the TGF-β pathway, it can also participate in receptor inhibition and signal termination in the BMP context.

6.2 Ubiquitination and Protein Degradation

(1) Smurf1/2-mediated negative regulation

Smurf family E3 ubiquitin ligases can promote degradation of receptors or Smad proteins, thereby weakening the persistence of BMP signaling.

(2) Balance between receptor endocytosis and degradation

BMP receptors can enter endosomal routes that continue to support signaling after endocytosis, but they can also be directed into degradative pathways. Different endocytic fates determine signal duration and peak intensity.

6.3 Linker Phosphorylation and Pathway Attenuation

The Smad1 linker region can be phosphorylated by kinases such as ERK and GSK3, promoting nuclear export and degradation. This mechanism enables BMP signaling to undergo competitive or sequential integration with other pathways such as FGF and Wnt.

7 Biological Functions of the BMP Pathway

7.1 Embryonic Development

(1) Dorsoventral axis and pattern formation

BMP gradients are key determinants of dorsoventral patterning in early embryos. Regions of high and low BMP activity specify different germ layer and tissue fates.

(2) Organogenesis

BMP signaling participates in development of the nervous system, cardiovascular system, limbs, kidney, lung, digestive tract, and multiple other organs. Its functions may be inductive or inhibitory depending on spatiotemporal context.

7.2 Bone and Cartilage Biology

(1) Osteogenic differentiation

BMP2, BMP4, BMP7, and related ligands promote differentiation of mesenchymal stem cells toward osteoblasts and induce programs such as Runx2, ALP, COL1A1, and BGLAP.

(2) Cartilage development and joint formation

GDF5/6/7 and parts of the BMP signaling network play key roles in chondrogenesis, maintenance of joint boundaries, and endplate structure.

7.3 Stem Cells and Tissue Homeostasis

(1) Stem cell fate regulation

BMP signaling plays important roles in embryonic stem cells, neural stem cells, hematopoietic stem cells, and the intestinal stem cell niche. Its output may promote maintenance of quiescence, bias differentiation, or suppress entry into specific lineages.

(2) Repair and regeneration

Following tissue injury, BMP signaling often participates in regulating the balance between proliferation and differentiation during regeneration, but the direction of its effect is highly tissue-specific and does not always simply promote repair.

7.4 Vascular and Metabolic Regulation

(1) Vascular homeostasis

The BMP9/10-ALK1-BMPR2 axis is important for endothelial quiescence, vascular maturation, and suppression of abnormal branching.

(2) Iron metabolism

The BMP6-HJV-SMAD axis controls hepcidin levels by regulating HAMP expression and is one of the core pathways governing systemic iron homeostasis.

Table 2. Major Biological Functions of the BMP Pathway

Functional Area	Representative Ligand/Module	Major Output
Embryonic pattern formation	BMP4, Chordin, Noggin	Dorsoventral axis formation, tissue boundary specification
Osteogenic differentiation	BMP2, BMP7, Smad1/5/8	Runx2 upregulation, activation of bone formation programs
Cartilage and joint development	GDF5/6/7	Chondrogenic differentiation, maintenance of joint structure
Vascular homeostasis	BMP9/10, ALK1, BMPR2	Endothelial homeostasis, control of vascular remodeling
Iron metabolism	BMP6, HJV, HAMP	Hepcidin regulation, balance of iron absorption and release
Stem cell regulation	Multiple BMPs and local antagonistic networks	Control of self-renewal and differentiation direction

8 Crosstalk Between the BMP Pathway and Other Signaling Networks

8.1 Relationship with the Wnt Pathway

BMP and Wnt often act synergistically in the osteogenic system, although in certain developmental settings they may also counterbalance each other. Together they determine whether cells enter differentiation programs and how mature the differentiation endpoint becomes.

8.2 Relationship with the FGF/ERK Pathway

FGF-ERK signaling can accelerate Smad1 inactivation through linker-region phosphorylation and therefore often antagonizes BMP signaling during development. For example, in neural induction and epidermal fate determination, the balance between BMP and FGF is decisive.

8.3 Relationship with Notch, Hedgehog, and Inflammatory Signaling

BMP and Notch can jointly regulate stem cell maintenance and angiogenesis; BMP and Hedgehog cooperate in bone development and organ patterning; crosstalk with inflammatory signaling influences fibrosis, repair, and the immune microenvironment.

9 Disease Associations of the BMP Pathway

9.1 Hereditary and Developmental Abnormalities

(1) Skeletal developmental abnormalities

Abnormalities in BMP ligands, receptors, or downstream factors can lead to defects in ossification, joint development, and skeletal patterning.

(2) Vascular disease

BMPR2 mutations are closely associated with hereditary pulmonary arterial hypertension and represent one of the most typical examples of clinical pathology involving the BMP pathway.

9.2 Fibrosis and Tissue Remodeling

BMP7 can antagonize TGF-β-like profibrotic outputs in some organ fibrosis models. The balance between BMP and TGF-β signaling is therefore often regarded as an important determinant of tissue-remodeling direction.

9.3 Bidirectional Effects in Tumors

The role of BMP signaling in tumors is highly context-dependent. In some tumors, BMP suppresses stemness maintenance and proliferation; in other settings, BMP may promote invasion, epithelial-mesenchymal transition, or microenvironmental remodeling. The BMP pathway therefore cannot be simply defined as either tumor-suppressive or tumor-promoting.

10 Experimental Research on the BMP Pathway and Interpretation of Results

10.1 Common Detection Indicators

(1) Receptor and ligand expression

Expression of BMP ligands, ALK1/2/3/6, BMPR2, and ACVR2A/B forms the basis for judging pathway potential, but the presence of expression does not necessarily mean that signaling is active.

(2) p-Smad1/5/8

This is one of the most commonly used direct readouts of canonical BMP pathway activation and can be detected by Western blotting, flow cytometry, or immunofluorescence.

(3) Target gene expression

Id1, Id2, Id3, Runx2, and HAMP are commonly used as downstream transcriptional readouts of BMP signaling in different systems.

10.2 Common Experimental Strategies

(1) Exogenous BMP stimulation

Stimulation of cells with recombinant proteins such as BMP2, BMP4, and BMP7, followed by analysis of p-Smad1/5/8 and target gene changes, is the most basic model for pathway activation.

(2) Receptor inhibition or antagonist intervention

Use of ALK inhibitors, Noggin, Chordin, or gene knockdown strategies can verify whether a given phenotype depends on BMP signaling.

(3) Lineage differentiation models

In osteogenic, chondrogenic, endothelial, and stem cell models, combining BMP pathway readouts with functional phenotypes provides greater interpretive power than expression analysis alone.

10.3 Common Biases in Data Interpretation

(1) Equating ligand expression with pathway activation

Detection of BMP ligand expression does not necessarily mean that cells are receiving effective signaling. Antagonistic proteins, receptor deficiency, or Smad impairment can all generate a state in which ligand is present but output is absent.

(2) Equating increased p-Smad1/5/8 with terminal function

An increase in p-Smad1/5/8 indicates that the pathway has been activated, but whether this is converted into osteogenesis, anti-fibrotic activity, or other terminal phenotypes depends on cellular context and the cooperating regulatory network.

(3) Ignoring the temporal dimension

BMP signaling is strongly time-dependent. Short-term stimulation, sustained stimulation, and pulsed stimulation may produce different transcriptional and functional consequences.

Table 3. Key Readouts for Experimental Analysis of the BMP Pathway

Observation Level	Common Indicators	Methodological Significance
Ligand level	BMP2/4/6/7/9 expression	Determine presence of the signal source
Receptor level	ALK1/2/3/6, BMPR2	Determine cellular signaling responsiveness
Canonical transduction	p-Smad1/5/8	Determine whether canonical BMP signaling is activated
Transcriptional output	Id1/2/3, Runx2, HAMP	Determine response of nuclear transcriptional programs
Functional level	Osteogenesis, differentiation, migration, proliferation	Determine whether signaling output is converted into phenotype

11 Product Tables Related to BMP Pathway Research

Table 4. BMP Ligand and Recombinant Protein Products

Catalog No.	Name	Grade and Purity	Suitable Research Direction/Application
rp173575	BMP-10	Moligand™	Suitable for BMP10 branch stimulation and ligand function studies
rp173576	BMP-15	Moligand™	Suitable for BMP15-related ligand function studies
rp173578	BMP-3	Moligand™	Suitable for BMP3 branch studies and pathway stimulation models
rp173580	BMP-5	Moligand™	Suitable for BMP5-related signaling studies
rp173581	BMP-6	Moligand™	Suitable for BMP6 pathway stimulation and iron metabolism/osteogenesis-related studies
rp173582	BMP-7	Moligand™	Suitable for BMP7 pathway stimulation and differentiation studies
rp173583	BMP-8A	Moligand™	Suitable for BMP8A branch studies
rp173584	BMP-8B	Moligand™	Suitable for BMP8B branch studies
rp173585	BMP-9	Moligand™	Suitable for studies on the BMP9-ALK1/BMPR2 axis
rp168355-GMP	Recombinant Human BMP-2 GMP Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,sterile,≥95%(SDS-PAGE)	Suitable for BMP2 stimulation, osteogenic induction, and high-grade research systems
rp164886-GMP	Recombinant Human BMP-4 GMP Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,His Tag,≥95%(SDS-PAGE),See COA	Suitable for BMP4 stimulation and developmental/differentiation model studies
rp330090	Recombinant Human BMP2 Protein	≥90%(SDS-PAGE)	Suitable for human BMP2 stimulation experiments
rp143300	Recombinant Human BMP3 Protein	ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥95%(SDS-PAGE&HPLC)	Suitable for BMP3 functional studies
rp329653	Recombinant Human BMP4 Protein	≥95%(SDS-PAGE)	Suitable for BMP4 stimulation experiments
rp329804	Recombinant Human BMP7 Protein	≥90%(SDS-PAGE)	Suitable for BMP7 stimulation and differentiation model studies
rp330131	Recombinant Human BMP9 Protein	≥90%(SDS-PAGE)	Suitable for BMP9-related endothelial/vascular signaling studies
rp330253	Recombinant Human BMP9 Protein	≥90%(SDS-PAGE)	Suitable for BMP9-related functional validation
rp330091	Recombinant Rat BMP2 Protein	≥90%(SDS-PAGE)	Suitable for rat BMP2 stimulation models

Table 5. BMP Pathway Agonist/Inhibitor and Receptor Tools

Catalog No.	Name	CAS No.	Grade and Purity	Suitable Research Direction/Application
B1448944	BMP agonist 1	—		Suitable for BMP pathway agonism studies
B1454659	BMP agonist 2	1438900-88-9	≥99%	Suitable for BMP pathway activation and function-enhancement models
B1454675	BMP2-derived peptide	836606-84-9	≥98%	Suitable for research on BMP2-derived active fragments
S286588	SB 4	100874-08-6	≥98%	Suitable for BMP4 agonism studies
D275100	DMH-1	1206711-16-1	≥98%	Suitable for studies of BMP type I receptor inhibition
D287316	DMH2	1206711-14-9	≥98%(HPLC)	Suitable for studies of type I BMP receptor inhibition
K287246	K 02288	1431985-92-0	≥98%	Suitable for studies of type I BMP receptor inhibition
L127229	LDN-193189	1062368-24-4	≥98%	Suitable for BMP type I receptor inhibition and pathway blockade studies
B1454661	BMPR2-IN-1	B1454661		Suitable for BMPR2-targeted inhibition studies
B1454692	BMPR2-IN-1 TFA	B1454692	≥99%	Suitable for BMPR2-targeted inhibition studies
rp143319	Recombinant Human BMPR-IA/ALK-3 Protein	—	Animal Free,Carrier Free,Bioactive,ActiBioPure™,Azide Free,His Tag,≥95%(SDS-PAGE),See COA	Suitable for BMP receptor binding and ALK3-related mechanistic studies
rp143325	Recombinant Human BMPR-IB/ALK-6 Protein	—	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,His Tag,≥90%(SDS-PAGE)	Suitable for ALK6-related receptor studies
rp329445	Recombinant Human BMPR2 Protein	—	≥90%(SDS-PAGE)	Suitable for BMPR2 receptor function and binding studies
rp143327	Recombinant Human BMPR2 protein	—	Animal Free,Carrier Free,Bioactive,ActiBioPure™,Azide Free,His Tag,≥95%(SDS-PAGE)	Suitable for BMPR2 receptor mechanistic studies

Table 6. Antibody Tools for BMP Pathway Research

Catalog No.	Name	Grade and Purity	Suitable Research Direction/Application
Ab091408	BMP10 Antibody	ExactAb™, Validated, 1.0 mg/mL	Suitable for BMP10 protein detection
Ab091421	BMP3 Antibody	ExactAb™, Validated, 1.0 mg/mL	Suitable for BMP3 protein detection
Ab091432	BMP6 Antibody	Carrier Free, ExactAb™, Validated, 1.0 mg/mL	Suitable for BMP6 protein detection
Ab091424	Recombinant BMP4 Antibody	Recombinant, ExactAb™, Validated, High Performance, See COA	Suitable for BMP4 protein detection
Ab091437	Recombinant BMP7 Antibody	Recombinant, ExactAb™, Validated, See COA	Suitable for BMP7 protein detection
Ab326508	Recombinant SMAD Family Member 1 Antibody	KD Validation	Suitable for Smad1 detection and is one of the core readouts of canonical BMP signaling
Ab327093	Recombinant SMAD5 Antibody	KD Validation	Suitable for Smad5 detection
Ab128237	SMAD5 Mouse mAb	ExactAb™, Validated, 1.6 mg/mL	Suitable for Smad5 protein detection
Ab128243	SMAD6 Antibody	Validated, ExactAb™, 1.0 mg/mL	Suitable for studies of Smad6-mediated negative feedback regulation
Ab128246	SMAD9 Antibody	Carrier Free, ExactAb™, Validated, High Performance, See COA	Suitable for Smad9 detection
Ab113970	MADH7/SMAD7 Antibody	Validated, 1.0 mg/mL	Suitable for studies of Smad7-mediated negative regulation
Ab325869	Recombinant Smad4 Antibody	KD Validation	Suitable for Smad4 detection and evaluation of the canonical BMP transcriptional complex
Ab128223	Recombinant Smad4 Antibody	ExactAb™, Validated, Recombinant, 0.6 mg/mL	Suitable for Smad4 protein detection

Table 7. ELISA Products for BMP Pathway Research

Catalog No.	Name	Grade and Purity	Suitable Research Direction/Application
H1121521	Human BMP-9/GDF2 ELISA kit	Bioactive, for enzyme immunoassay(ELISA), for ELISA	Suitable for quantitative detection of human BMP9/GDF2
EJ1514295	Human Growth Differentiation Factor 2 (GDF-2/BMP-9) ELISA Kit	BioReagent	Suitable for detection of human BMP9/GDF2
EJ1515122	Human Bone Morphogenetic Protein 15 (BMP15) ELISA Kit	BioReagent	Suitable for detection of human BMP15
EJ1515123	Human Bone Morphogenetic Protein 6 (BMP6) ELISA Kit	BioReagent	Suitable for detection of human BMP6
EJ1515125	Human Bone Morphogenetic Protein 10 (BMP10) ELISA Kit	BioReagent	Suitable for detection of human BMP10
EJ1515126	Human Bone Morphogenetic Protein 2 (BMP2) ELISA Kit	BioReagent	Suitable for detection of human BMP2
EJ1515127	Human Bone Morphogenetic Protein 3 (BMP3) ELISA Kit	BioReagent	Suitable for detection of human BMP3
EJ1515128	Human Bone Morphogenetic Protein 4 (BMP4) ELISA Kit	BioReagent	Suitable for detection of human BMP4
EJ1515129	Human Bone Morphogenetic Protein 5 (BMP5) ELISA Kit	BioReagent	Suitable for detection of human BMP5
EJ1515124	Human Bone Morphogenetic Protein 7 (BMP7) ELISA Kit	BioReagent	Suitable for detection of human BMP7
EJ1512123	Rat Growth Differentiation Factor 2 (GDF-2/BMP-9) ELISA Kit	BioReagent	Suitable for detection of rat BMP9/GDF2
EJ1512422	Rat Bone Morphogenetic Protein 2 (BMP2) ELISA Kit	BioReagent	Suitable for detection of rat BMP2
EJ1512423	Rat Bone Morphogenetic Protein 4 (BMP4) ELISA Kit	BioReagent	Suitable for detection of rat BMP4
EJ1512424	Rat Bone Morphogenetic Protein 7 (BMP7) ELISA Kit	BioReagent	Suitable for detection of rat BMP7
EJ1513363	Mouse Bone Morphogenetic Protein 15 (BMP15) ELISA Kit	BioReagent	Suitable for detection of mouse BMP15
EJ1513364	Mouse Bone Morphogenetic Protein 6 (BMP-6) ELISA Kit	BioReagent	Suitable for detection of mouse BMP6
EJ1513365	Mouse Bone Morphogenetic Protein 8B (BMP8B) ELISA Kit	BioReagent	Suitable for detection of mouse BMP8B
EJ1513367	Mouse Bone Morphogenetic Protein 2 (BMP-2) ELISA Kit	BioReagent	Suitable for detection of mouse BMP2
EJ1513368	Mouse Bone Morphogenetic Protein 4 (BMP4) ELISA Kit	BioReagent	Suitable for detection of mouse BMP4
EJ1513637	Human Mothers Against Decapentaplegic Homolog 4 (Smad4) ELISA Kit	BioReagent	Suitable for Smad4 detection as a common-Smad readout of canonical BMP signaling
EJ1513638	Human SMAD Family Member 5(Smad5) ELISA Kit	BioReagent	Suitable for Smad5 detection as a key downstream BMP readout
EJ1513639	Human Mothers Against Decapentaplegic Homolog 7 (Smad7) ELISA Kit	BioReagent	Suitable for detection of Smad7-mediated negative feedback regulation
EJ1512554	Mouse Mothers Against Decapentaplegic Homolog 4 (Smad4) ELISA Kit	BioReagent	Suitable for mouse Smad4 detection

The essential nature of the BMP pathway is that it is a multilayered regulatory system composed of ligands, receptors, antagonistic networks, the Smad transcriptional module, and noncanonical branches. Its biological significance does not lie in a single signal promoting a single endpoint, but in controlling cell fate and tissue homeostasis through signal intensity, timing, and spatial distribution.

For more related articles, please see below:

[1] Ras-Raf-MEK-ERK Signaling

[2] Wnt/β-Catenin Signaling Pathway

[3] How to Map the NF-κB Pathway and Choose Inhibitors: Bringing Inflammatory Transcriptional Output into a “Controllable Range” (Tables A–F)

[4] Metabolic signaling pathway

[5] Wnt Signaling

[6] Hedgehog Signaling

[7] JAK-STAT Cell Signaling Pathway

[8] PD-1/PD-L1 Signaling Pathway